Imaging & Biomarker Correlates on Outcomes in a Phase II Trial of Neoadjuvant Gemcitabine/Nab-Paclitaxel and Hypofractionated Image-Guided Radiotherapy (HIGRT) in Potentially Resectable Pancreas Cancer

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Kent, CL; Marin, D; Niedzwiecki, D; Stephens, SJ; Duffy, E; Malicki, M; Abbruzzese, J; Uronis, H; Blobe, G; Blazer, DG; Czito, B; Willett, CG; Palta, M

Published Date

  • September 2019

Published In

Volume / Issue

  • 105 / 1

Start / End Page

  • E238 - E239

Published By

International Standard Serial Number (ISSN)

  • 0360-3016

Digital Object Identifier (DOI)

  • 10.1016/j.ijrobp.2019.06.2014